Volume : 12, Issue : 09, September – 2025
Title:
A COMPREHENSIVE REVIEW ON THE MEDICINAL APPLICATIONS AND PHARMACOLOGICAL PROPERTIES OF CANNABIS
Authors :
Aditya Anil Nagargoje,Nayan Raut,Dharmraj Ankush Kekan,Dr. Vivek Kashid
Abstract :
Cannabis is one of the oldest known medicinal plants, recognized for its extensive pharmacological and therapeutic potential. Its principal bioactive compounds, tetrahydrocannabinol (THC) and cannabidiol (CBD), modulate the endocannabinoid system, influencing pain, inflammation, neurological function, mood, and immune responses. Additional phytochemicals, including terpenes and flavonoids, enhance its therapeutic effects through the entourage effect. Cannabis has shown potential in managing chronic pain, epilepsy, neurodegenerative disorders, psychiatric conditions, cancer, and gastrointestinal ailments. Despite its medicinal benefits, cannabis also poses risks, such as psychoactive effects, dependence, cognitive impairment, and regulatory challenges. This review comprehensively examines the botanical, chemical, pharmacological, therapeutic, and safety aspects of cannabis while exploring current research trends and future prospects.
Keywords: Cannabis, Cannabinoids, THC, CBD, Endocannabinoid System, Pharmacology, Medicinal Uses, Therapeutics, Safety, Future Prospects
Cite This Article:
Please cite this article in press Aditya Anil Nagargoje et al., A Comprehensive Review On The Medicinal Applications And Pharmacological Properties Of Cannabis, Indo Am. J. P. Sci, 2025; 12(09).
REFERENCES:
1. Aher, K. B., Bhosale, S., Bhavar, G. B., Habeeb, M., & You, H. W. (2025). Development and optimization of polymeric nanosponges for enhanced delivery of diflunisal in rheumatoid arthritis. International Journal of Nano Dimension, 16(2), 145–158.
2. Basavarajappa, B. S., Shivakumar, M., & Subbanna, S. (2021). Endocannabinoid system: Emerging therapeutic target in neurodegenerative disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 105, 110158.
3. Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825–836.
4. Di Marzo, V. (2008). Endocannabinoids: Synthesis and degradation. Reviews of Physiology, Biochemistry and Pharmacology, 160, 1–24.
5. ElSohly, M. A., & Slade, D. (2005). Chemical constituents of marijuana: The complex mixture of natural cannabinoids. Life Sciences, 78(5), 539–548.
6. Huestis, M. A., Solimini, R., Pichini, S., Pacifici, R., Carlier, J., & Busardò, F. P. (2019). Cannabidiol adverse effects and toxicity. Current Neuropharmacology, 17(10), 974–989.
7. Kogan, N. M., & Mechoulam, R. (2007). Cannabinoids in health and disease. Dialogues in Clinical Neuroscience, 9(4), 413–430.
8. Kumar, A., Kumar, V., & Sharma, A. (2020). Pharmacological overview of cannabis and cannabinoids: Therapeutic potentials and adverse effects. Journal of Pharmaceutical Sciences and Research, 12(6), 725–733.
9. Russo, E. B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
10. Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol, and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215.
11. Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47.
12. Hill, K. P., Palastro, M. D., Johnson, B., & Ditre, J. W. (2017). Cannabis and pain: A clinical review. Cannabis and Cannabinoid Research, 2(1), 96–104.
13. Zuardi, A. W. (2008). Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action. Revista Brasileira de Psiquiatria, 30(3), 271–280.
14. Grotenhermen, F., & Müller-Vahl, K. (2012). The therapeutic potential of cannabis and cannabinoids. Deutsches Ärzteblatt International, 109(29–30), 495–501.
15. Whiting, P. F., Wolff, R. F., Deshpande, S., et al. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456–2473.
16. Ashton, C. H. (2001). Pharmacology and effects of cannabis: A brief review. British Journal of Psychiatry, 178, 101.